BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Thenappan T, Khoruts A, Chen Y, Weir EK. Can intestinal microbiota and circulating microbial products contribute to pulmonary arterial hypertension? Am J Physiol Heart Circ Physiol 2019;317:H1093-101. [PMID: 31490732 DOI: 10.1152/ajpheart.00416.2019] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
Number Citing Articles
1 Tiboldi A, Hunyadi-gulyas E, Wohlrab P, Schmid JA, Markstaller K, Klein KU, Tretter V. Effects of Hyperoxia and Hyperoxic Oscillations on the Proteome of Murine Lung Microvascular Endothelium. Antioxidants 2022;11:2349. [DOI: 10.3390/antiox11122349] [Reference Citation Analysis]
2 Chen M, Chen Y, Ud Din I. Bioinformatics Analysis of Common Genetic and Molecular Traits and Association of Portal Hypertension with Pulmonary Hypertension. Journal of Healthcare Engineering 2022;2022:1-12. [DOI: 10.1155/2022/9237701] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Wu P, Zhu T, Tan Z, Chen S, Fang Z. Role of Gut Microbiota in Pulmonary Arterial Hypertension. Front Cell Infect Microbiol 2022;12:812303. [DOI: 10.3389/fcimb.2022.812303] [Reference Citation Analysis]
4 Huang CX, Jiang ZX, Du DY, Zhang ZM, Liu Y, Li YT. The MFF-SIRT1/3 axis, regulated by miR-340-5p, restores mitochondrial homeostasis of hypoxia-induced pulmonary artery smooth muscle cells. Lab Invest 2022;102:515-23. [PMID: 35042949 DOI: 10.1038/s41374-022-00730-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Yu Z, Xiao J, Chen X, Ruan Y, Chen Y, Zheng X, Wang Q. Bioactivities and mechanisms of natural medicines in the management of pulmonary arterial hypertension. Chin Med 2022;17. [DOI: 10.1186/s13020-022-00568-w] [Reference Citation Analysis]
6 Moutsoglou DM. 2021 ATS BEAR Cage Winning Proposal: Microbiome Transplant in Pulmonary Arterial Hypertension. Am J Respir Crit Care Med 2021. [PMID: 34758276 DOI: 10.1164/rccm.202108-1833ED] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
7 Xue Z, Li Y, Zhou M, Liu Z, Fan G, Wang X, Zhu Y, Yang J. Traditional Herbal Medicine Discovery for the Treatment and Prevention of Pulmonary Arterial Hypertension. Front Pharmacol 2021;12:720873. [PMID: 34899290 DOI: 10.3389/fphar.2021.720873] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
8 Li L, Yin M, Hu L, Tian X, He X, Zhao C, Li Y, Li Q, Li X. Novel Pyrazolo[3,4-b] Pyridine Derivative (HLQ2g) Attenuates Hypoxic Pulmonary Hypertension via Restoring cGKI Expression and BMP Signaling Pathway. Front Pharmacol 2021;12:691405. [PMID: 34658848 DOI: 10.3389/fphar.2021.691405] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Carrillo-Salinas FJ, Anastasiou M, Ngwenyama N, Kaur K, Tai A, Smolgovsky SA, Jetton D, Aronovitz M, Alcaide P. Gut dysbiosis induced by cardiac pressure overload enhances adverse cardiac remodeling in a T cell-dependent manner. Gut Microbes 2020;12:1-20. [PMID: 33103561 DOI: 10.1080/19490976.2020.1823801] [Cited by in Crossref: 34] [Cited by in F6Publishing: 13] [Article Influence: 34.0] [Reference Citation Analysis]
10 Karoor V, Strassheim D, Sullivan T, Verin A, Umapathy NS, Dempsey EC, Frank DN, Stenmark KR, Gerasimovskaya E. The Short-Chain Fatty Acid Butyrate Attenuates Pulmonary Vascular Remodeling and Inflammation in Hypoxia-Induced Pulmonary Hypertension. Int J Mol Sci 2021;22:9916. [PMID: 34576081 DOI: 10.3390/ijms22189916] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
11 Hong W, Mo Q, Wang L, Peng F, Zhou Y, Zou W, Sun R, Liang C, Zheng M, Li H, Zhao D, Gao M, Pu J, Li B, Ran P, Peng G. Changes in the gut microbiome and metabolome in a rat model of pulmonary arterial hypertension. Bioengineered 2021;12:5173-83. [PMID: 34405758 DOI: 10.1080/21655979.2021.1952365] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
12 Wilkins MR. Personalized Medicine for Pulmonary Hypertension:: The Future Management of Pulmonary Hypertension Requires a New Taxonomy. Clin Chest Med 2021;42:207-16. [PMID: 33541614 DOI: 10.1016/j.ccm.2020.10.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Yao K, Wang S, Gaowa N, Huang S, Li S, Shao W. Identification of the molecular mechanisms underlying brisket disease in Holstein heifers via microbiota and metabolome analyses. AMB Express 2021;11:86. [PMID: 34185184 DOI: 10.1186/s13568-021-01246-0] [Reference Citation Analysis]
14 Sanada TJ, Hosomi K, Shoji H, Park J, Naito A, Ikubo Y, Yanagisawa A, Kobayashi T, Miwa H, Suda R, Sakao S, Mizuguchi K, Kunisawa J, Tanabe N, Tatsumi K. Gut microbiota modification suppresses the development of pulmonary arterial hypertension in an SU5416/hypoxia rat model. Pulm Circ 2020;10:2045894020929147. [PMID: 32922743 DOI: 10.1177/2045894020929147] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
15 Sharma RK, Oliveira AC, Yang T, Kim S, Zubcevic J, Aquino V, Lobaton GO, Goel R, Richards EM, Raizada MK. Pulmonary arterial hypertension-associated changes in gut pathology and microbiota. ERJ Open Res 2020;6:00253-2019. [PMID: 32743008 DOI: 10.1183/23120541.00253-2019] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
16 Harbaum L, Rhodes CJ, Otero-Núñez P, Wharton J, Wilkins MR. The application of 'omics' to pulmonary arterial hypertension. Br J Pharmacol 2021;178:108-20. [PMID: 32201940 DOI: 10.1111/bph.15056] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
17 Rafikov R, Coletta DK, Mandarino LJ, Rafikova O. Pulmonary Arterial Hypertension Induces a Distinct Signature of Circulating Metabolites. J Clin Med 2020;9:E217. [PMID: 31947516 DOI: 10.3390/jcm9010217] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
18 Callejo M, Barberá JA, Duarte J, Perez-Vizcaino F. Impact of Nutrition on Pulmonary Arterial Hypertension. Nutrients 2020;12:E169. [PMID: 31936113 DOI: 10.3390/nu12010169] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
19 Heo S, Ly N, Aqil M, Shahid M, Siddiqui MR, Ahmad Z, Tauseef M. Therapeutic Advances in the Management of Pulmonary Arterial Hypertension. Chronic Lung Diseases 2020. [DOI: 10.1007/978-981-15-3734-9_1] [Reference Citation Analysis]